Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dapagliflozin in Respiratory Failure in Patients With COVID-19 (DARE-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04350593
Recruitment Status : Active, not recruiting
First Posted : April 17, 2020
Last Update Posted : May 12, 2021
Sponsor:
Collaborators:
Saint Luke's Hospital of Kansas City
AstraZeneca
George Clinical Pty Ltd
Information provided by (Responsible Party):
Saint Luke's Health System

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 1, 2021
Estimated Study Completion Date : June 2021